Acacia Pharma Group

Acacia Pharma is a commercial-stage biopharmaceutical company focused on the development and commercialization of new products. Our goal is to improve the care of patients undergoing serious medical treatments, such as surgery, invasive procedures, or chemotherapy. The company has identified significant and commercially attractive unmet needs in these areas that its product portfolio aims to address. View our products for sale here. Acacia Pharma has its own commercial infrastructure in the United States, through which it directly markets and sells its products. Acacia Pharma intends to establish licensing and/or distribution agreements for Barhemsys and APD403 with selected pharmaceutical partners outside the United States. The company's management team and board have extensive experience in the development and commercialization of hospital medicines. Acacia Pharma was founded in 2007 and has offices in Cambridge, UK, and Indianapolis, Indiana, USA.